Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 376.77B | 379.19B | 370.75B | 379.40B | 376.09B | 385.70B |
Gross Profit | 120.11B | 117.53B | 127.21B | 132.06B | 131.86B | 136.92B |
EBITDA | 32.59B | 33.39B | 32.84B | 37.87B | 39.60B | 41.81B |
Net Income | 13.20B | 13.72B | 13.71B | 17.10B | 17.90B | 20.40B |
Balance Sheet | ||||||
Total Assets | 375.52B | 386.66B | 372.85B | 361.39B | 354.79B | 348.16B |
Cash, Cash Equivalents and Short-Term Investments | 21.31B | 16.34B | 16.75B | 14.11B | 19.42B | 17.30B |
Total Debt | 29.48B | 34.93B | 34.25B | 31.94B | 39.80B | 45.47B |
Total Liabilities | 130.32B | 140.34B | 136.60B | 134.04B | 140.95B | 147.60B |
Stockholders Equity | 245.21B | 246.32B | 236.25B | 227.35B | 213.84B | 200.56B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 6.49B | 6.03B | 8.60B | 15.18B | 22.67B |
Operating Cash Flow | 0.00 | 23.12B | 21.36B | 19.87B | 25.86B | 36.55B |
Investing Cash Flow | 0.00 | -18.20B | -15.43B | -11.66B | -11.26B | -14.23B |
Financing Cash Flow | 0.00 | -5.25B | -3.29B | -13.50B | -12.48B | -14.57B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
71 Outperform | ¥147.33B | 10.25 | 1.82% | 2.28% | 1.10% | ||
67 Neutral | ¥252.14B | 13.51 | 6.48% | 2.73% | 5.20% | -11.34% | |
€300.04M | 241.13 | 0.09% | 3.22% | ― | ― | ||
79 Outperform | ¥179.34B | 10.50 | 3.23% | 6.96% | -19.43% | ||
78 Outperform | ¥124.13B | 13.91 | 0.48% | 2.78% | 15.97% | ||
67 Neutral | ¥125.06B | 8.22 | 2.51% | 4.89% | 7.47% | ||
64 Neutral | ¥31.81B | 15.24 | 1.50% | 4.31% | 11.77% |